Phase 4 is post FDA approval collection of data.
Ann: Media release - First stroke patient with afamelanotide, page-20
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.55 |
Change
0.000(0.00%) |
Mkt cap ! $724.1M | |||
| Open | High | Low | Value | Volume |
| $14.60 | $14.60 | $14.32 | $547.4K | 37.81K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 390 | $14.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.55 | 15 | 2 |
View Market Depth
| Last trade - 14.33pm 10/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |